BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 18301802)

  • 1. Lacosamide: an investigational drug for adjunctive treatment of partial-onset seizures.
    Ben-Menachem E
    Drugs Today (Barc); 2008 Jan; 44(1):35-40. PubMed ID: 18301802
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lacosamide: an adjunctive agent for partial-onset seizures and potential therapy for neuropathic pain.
    Harris JA; Murphy JA
    Ann Pharmacother; 2009 Nov; 43(11):1809-17. PubMed ID: 19843834
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and tolerability of lacosamide as adjunctive therapy for adults with partial-onset seizures: Analysis of data pooled from three randomized, double-blind, placebo-controlled clinical trials.
    Biton V; Gil-Nagel A; Isojarvi J; Doty P; Hebert D; Fountain NB
    Epilepsy Behav; 2015 Nov; 52(Pt A):119-27. PubMed ID: 26414341
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term safety and efficacy in patients with uncontrolled partial-onset seizures treated with adjunctive lacosamide: results from a Phase III open-label extension trial.
    Husain A; Chung S; Faught E; Isojarvi J; McShea C; Doty P
    Epilepsia; 2012 Mar; 53(3):521-8. PubMed ID: 22372628
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lacosamide: a review of its use as adjunctive therapy in the management of partial-onset seizures.
    Hoy SM
    CNS Drugs; 2013 Dec; 27(12):1125-42. PubMed ID: 24203890
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A noninterventional study evaluating the effectiveness and safety of lacosamide added to monotherapy in patients with epilepsy with partial-onset seizures in daily clinical practice: The VITOBA study.
    Runge U; Arnold S; Brandt C; Reinhardt F; Kühn F; Isensee K; Ramirez F; Dedeken P; Lauterbach T; Noack-Rink M; Mayer T
    Epilepsia; 2015 Dec; 56(12):1921-30. PubMed ID: 26526971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of oral lacosamide as adjunctive therapy in adults with partial-onset seizures.
    Ben-Menachem E; Biton V; Jatuzis D; Abou-Khalil B; Doty P; Rudd GD
    Epilepsia; 2007 Jul; 48(7):1308-17. PubMed ID: 17635557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and tolerability of adjunctive lacosamide intravenous loading dose in lacosamide-naive patients with partial-onset seizures.
    Fountain NB; Krauss G; Isojarvi J; Dilley D; Doty P; Rudd GD
    Epilepsia; 2013 Jan; 54(1):58-65. PubMed ID: 22708895
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and efficacy of adjunctive lacosamide among patients with partial-onset seizures in a long-term open-label extension trial of up to 8 years.
    Rosenfeld W; Fountain NB; Kaubrys G; Ben-Menachem E; McShea C; Isojarvi J; Doty P;
    Epilepsy Behav; 2014 Dec; 41():164-70. PubMed ID: 25461210
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lacosamide and epilepsy.
    Harris JA; Murphy JA
    CNS Neurosci Ther; 2011 Dec; 17(6):678-82. PubMed ID: 20950330
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lacosamide: in partial-onset seizures.
    Cross SA; Curran MP
    Drugs; 2009; 69(4):449-59. PubMed ID: 19323588
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lacosamide for the prevention of partial onset seizures in epileptic adults.
    Kelemen A; Halász P
    Neuropsychiatr Dis Treat; 2010 Sep; 6():465-71. PubMed ID: 20856610
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adjunctive lacosamide for partial-onset seizures: Efficacy and safety results from a randomized controlled trial.
    Halász P; Kälviäinen R; Mazurkiewicz-Beldzińska M; Rosenow F; Doty P; Hebert D; Sullivan T;
    Epilepsia; 2009 Mar; 50(3):443-53. PubMed ID: 19183227
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lacosamide: A Review in Focal Seizures in Patients with Epilepsy.
    Scott LJ
    Drugs; 2015 Dec; 75(18):2143-54. PubMed ID: 26607484
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and tolerability of lacosamide as an adjunctive therapy in children with refractory partial epilepsy.
    Pasha I; Kamate M; Didagi SK
    Pediatr Neurol; 2014 Oct; 51(4):509-14. PubMed ID: 25266613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Lacosamide. A new antiepileptic drug as adjunctive therapy in patients with partial-onset seizures].
    Saussele T
    Med Monatsschr Pharm; 2008 Oct; 31(10):374-7. PubMed ID: 18972867
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of lacosamide in infants and young children with refractory focal epilepsy.
    Grosso S; Parisi P; Spalice A; Verrotti A; Balestri P
    Eur J Paediatr Neurol; 2014 Jan; 18(1):55-9. PubMed ID: 24129195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lacosamide.
    Doty P; Rudd GD; Stoehr T; Thomas D
    Neurotherapeutics; 2007 Jan; 4(1):145-8. PubMed ID: 17199030
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lacosamide for the treatment of epilepsy.
    Krauss GL; Edwards HB; Lin B
    Ann Med; 2012 Nov; 44(7):674-9. PubMed ID: 22380697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adjunctive lacosamide for focal epilepsy: an open-label trial evaluating the impact of flexible titration and dosing on safety and seizure outcomes.
    Baulac M; Coulbaut S; Doty P; McShea C; De Backer M; Bartolomei F; Vlaicu M
    Epileptic Disord; 2017 Jun; 19(2):186-194. PubMed ID: 28597842
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.